← Eichor
Study identifier: NCT07314840 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis

Condition: Lateral Epicondylitis · Lateral Elbow Tendinopathy (Tennis Elbow)  ·  Sponsor: Marmara University

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

Lateral epicondylitis (LE) is the tendinopathy of the common extensor tendon. Although exact etiology remains unclear, it is believed to be caused by overuse. Even though, genetics factor related to tendinopathies were defined accompanying tendinopathies in patients with LE is yet to be studied. Madrid sonographic enthesitis index (MASEI) is an ultrasound based scoring system, developed for the evaluation of the enthesitis. Initially developed for ankylosing spondylitis, its usage has also become widespread in other musculoskeletal diseases. The aim of this study is to calculate the MASEI score in patients diagnosed with LE, and compare it to healthy volunteers.

This description comes directly from the study's public registry record.

Talk to the study team

Arda Can Kasap, MD  ·  905384590119  ·  drardakasap@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Marmara UniversityIstanbul, Maltepe, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07314840